Jacobs (NYSE:J) was selected to provide program management and consultancy services to support the delivery of more than $800 million in critical infrastructure upgrades for King County Wastewater Treatment Division. Improvements will enhance water quality and system resiliency for approximately two million people in Seattle and across the central Puget Sound region.
Jacobs (NYSE:J) was selected by FUJIFILM Diosynth Biotechnologies to support delivery of $1.2 billion expansion of an end-to-end, large-scale cell culture contract manufacturing site in Holly Springs, North Carolina. Jacobs was originally selected to support the construction for the FUJIFILM Diosynth Biotechnologies' Holly Springs site, which broke ground in 2021. Jacobs will provide engineering, procurement and construction management services for the site's latest expansion.
Key Insights Significantly high institutional ownership implies Jacobs Solutions' stock price is sensitive to their...